LATEST DISCOUNTS & SALES: PROMOTIONS

Close Notification

Your cart does not contain any items

$179

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
CRC Press Inc
02 November 2018
Many experts now consider genetic evaluation to be pivotal for the optimal diagnosis, classification, risk stratification, and therapeutic decision-making for persons diagnosed with blood cancer. This new text specifically focuses on the genetic alterations essential for establishing diagnosis and assesses how they might impact the precision oncology standard of care. Providing an authoritative review of the state of the art, this is essential reading for physicians, hematologists, and oncologists for optimal management of individual patients.

By:  
Imprint:   CRC Press Inc
Country of Publication:   United States
Dimensions:   Height: 254mm,  Width: 178mm, 
Weight:   632g
ISBN:   9781498746991
ISBN 10:   1498746993
Pages:   242
Publication Date:  
Audience:   Professional and scholarly ,  College/higher education ,  Undergraduate ,  Primary
Format:   Paperback
Publisher's Status:   Active

Tariq I Mughal, MD, FRCP, FACP, graduated in medicine from St George's Hospital Medical School, London, and trained in hematology, medical oncology and stem cell transplantation at the University of Colorado Health Sciences Center, Denver. He is Clinical Professor of Medicine at Tufts University School of Medicine, Boston, Consultant Hematologist at Kings College NHS Foundation Trust, London, Professor of Hematology and Oncology at the University of Buckingham Medical School, UK, and the founder of Apline Oncology Foundation.

See Also